Search Results 1531-1540 of 38863 for Two-phase

  1. Publications - Harry H. Yoon, M.D. - Mayo Clinic

    ... Two Cases of Metastatic Gastroesophageal Adenocarcinoma. Oncologist ... Phase 2 Clinical KEYNOTE-059 Trial. JAMA Oncol. 2018 May 10; 4 (5):e180013

  2. Kidney Cancer Clinical Trials - Mayo Clinic Research

    Mayo Clinic will be participating in both Part A (Phase 1) & (Phase 2) B of the study. ... There are two parts in this study. During the escalation part ...

  3. Expertise in the nuances of diagnosis, management and surgery for vascular rings - Mayo Clinic

    In teens and adults, repairs often are performed in two stages, with vascular surgeons rerouting the subclavian artery with a small incision by the ...

  4. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Breast reconstruction with implants - Mayo Clinic

    There are two main kinds of breast reconstruction. One uses implants and the other uses tissue flaps. Breast reconstruction with flap surgery uses tissue from ...

  6. CAR-T Cell Therapy Clinical Trials - Mayo Clinic Research

    This trial is a phase 1b/2, open-label, multicenter study of GC012F (AZD0120), a CD19/BCMA dual CART-cell therapy, in adult subjects with relapsed/refractory ...

  7. Ulixertinib in People With Histiocytic Neoplasms - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Lynch syndrome - Diagnosis and treatment - Mayo Clinic

    ... 2 to 5 years earlier than the youngest age at diagnosis of colorectal cancer in their family. Colonoscopies should be repeated every 1 to 2 years. A ...

  9. An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy - Mayo Clinic

    The primary objective of study Part A is to assess the safety of talacotuzumab (formerly CSL362) monotherapy and confirm the recommended Phase 2 dose (RP2D) in ...

  10. Efficacy And Safety Of Nemtabrutinib (MK-1026) In Participants With Hematologic Malignancies (MK-1026-003) - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...